See how we have strategically helped other clinical trials. Case Studies
Pia Mikkelsen-Lynch, MD
Pia Mikkelsen Lynch, M.D. is a pharmaceutical consultant with more than 15 years of pharmaceutical industry experience. Dr. Lynch provides a full range of services from Pre-Clinical Consulting and Development Planning, through the Clinical Development Phases I-IV as well as Post-Marketing Support for Pharmaceutical, Biologic and Medical Device Companies.
Dr. Lynch received her M.D. degree from the Faculty of Medicine, University of Aarhus, Denmark and performed her research fellow and post-doctoral training at the Department of Hematology and Oncology & the Department of Bone Marrow Transplantation, University of Aarhus, Denmark; where she was the Clinical Project Leader for Phase I, II and III trials evaluating the use of growth factors GM-CSF, G-CSF, IL-3, IL-6 and treatment with antiemetic Zofran® in patients.
Prior to working as a consultant, Dr. Lynch was Vice President, Global Clinical Affairs, Novoste Corporation with the overall responsibility for the planning and execution of clinical development programs worldwide on all Novoste product lines and as Director for Clinical Research, Élan Pharmaceuticals, Inc., Dr. Lynch was responsible for developing business and clinical strategies for various projects in multi-therapeutic areas with the breadth of technologies offered as oral, micro particulate, transdermal and subcutaneous drug delivery systems. She has participated on teams that have produced INDs, NDAs, DMF, and CE Mark Approval Applications.
Dr. Lynch is the lead medical council for ICTS' Medical Science Liaison (MSL) programs.